The Food and Drug Administration (FDA) recently rejected clinical trials of an experimental drug to combat diabetes. While this drug showed no dangerous side effects and had tremendous promise is reducing diabetes, the FDA failed to approve it, citing incomplete regulatory paperwork.
Here, the FDA has committed what kind of error?
|